HP1B3_HUMAN - dbPTM
HP1B3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID HP1B3_HUMAN
UniProt AC Q5SSJ5
Protein Name Heterochromatin protein 1-binding protein 3
Gene Name HP1BP3
Organism Homo sapiens (Human).
Sequence Length 553
Subcellular Localization Nucleus . Chromosome . localized in nuclei but not in nucleoli in interphase. Colocalized with chromosomes in mitosis, with a gradually increased during G1 progression and a maximum level during late G1 phase (G1/S).
Protein Description Component of heterochromatin that maintains heterochromatin integrity during G1/S progression and regulates the duration of G1 phase to critically influence cell proliferative capacity. [PubMed: 24830416). Mediates chromatin condensation during hypoxia]
Protein Sequence MATDTSQGELVHPKALPLIVGAQLIHADKLGEKVEDSTMPIRRTVNSTRETPPKSKLAEGEEEKPEPDISSEESVSTVEEQENETPPATSSEAEQPKGEPENEEKEENKSSEETKKDEKDQSKEKEKKVKKTIPSWATLSASQLARAQKQTPMASSPRPKMDAILTEAIKACFQKSGASVVAIRKYIIHKYPSLELERRGYLLKQALKRELNRGVIKQVKGKGASGSFVVVQKSRKTPQKSRNRKNRSSAVDPEPQVKLEDVLPLAFTRLCEPKEASYSLIRKYVSQYYPKLRVDIRPQLLKNALQRAVERGQLEQITGKGASGTFQLKKSGEKPLLGGSLMEYAILSAIAAMNEPKTCSTTALKKYVLENHPGTNSNYQMHLLKKTLQKCEKNGWMEQISGKGFSGTFQLCFPYYPSPGVLFPKKEPDDSRDEDEDEDESSEEDSEDEEPPPKRRLQKKTPAKSPGKAASVKQRGSKPAPKVSAAQRGKARPLPKKAPPKAKTPAKKTRPSSTVIKKPSGGSSKKPATSARKEVKLPGKGKSTMKKSFRVKK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MATDTSQGE
------CCCCCCCCC
17.7420068231
3Phosphorylation-----MATDTSQGEL
-----CCCCCCCCCC
38.2122167270
5Phosphorylation---MATDTSQGELVH
---CCCCCCCCCCCC
20.7029255136
6Phosphorylation--MATDTSQGELVHP
--CCCCCCCCCCCCC
38.7123401153
9 (in isoform 2)Phosphorylation-39.7329116813
13 (in isoform 2)Phosphorylation-19.0129116813
14UbiquitinationQGELVHPKALPLIVG
CCCCCCCCHHHHEEE
47.9121890473
14 (in isoform 1)Ubiquitination-47.9121890473
14 (in isoform 5)Ubiquitination-47.9121890473
292-HydroxyisobutyrylationAQLIHADKLGEKVED
EEEEEHHHHCCCCCC
60.21-
29AcetylationAQLIHADKLGEKVED
EEEEEHHHHCCCCCC
60.2123749302
29UbiquitinationAQLIHADKLGEKVED
EEEEEHHHHCCCCCC
60.2133845483
33UbiquitinationHADKLGEKVEDSTMP
EHHHHCCCCCCCCCC
49.4833845483
37PhosphorylationLGEKVEDSTMPIRRT
HCCCCCCCCCCCCCC
17.0726074081
38PhosphorylationGEKVEDSTMPIRRTV
CCCCCCCCCCCCCCC
39.0126074081
39SulfoxidationEKVEDSTMPIRRTVN
CCCCCCCCCCCCCCC
2.7721406390
44PhosphorylationSTMPIRRTVNSTRET
CCCCCCCCCCCCCCC
17.7526055452
47PhosphorylationPIRRTVNSTRETPPK
CCCCCCCCCCCCCCH
25.2223401153
48PhosphorylationIRRTVNSTRETPPKS
CCCCCCCCCCCCCHH
27.5923401153
51PhosphorylationTVNSTRETPPKSKLA
CCCCCCCCCCHHHCC
41.4225159151
55PhosphorylationTRETPPKSKLAEGEE
CCCCCCHHHCCCCCC
38.3823403867
64SumoylationLAEGEEEKPEPDISS
CCCCCCCCCCCCCCC
58.9428112733
70PhosphorylationEKPEPDISSEESVST
CCCCCCCCCCHHCCC
38.7930278072
71PhosphorylationKPEPDISSEESVSTV
CCCCCCCCCHHCCCH
45.8030278072
74PhosphorylationPDISSEESVSTVEEQ
CCCCCCHHCCCHHHH
19.8130278072
76PhosphorylationISSEESVSTVEEQEN
CCCCHHCCCHHHHCC
35.6930278072
77PhosphorylationSSEESVSTVEEQENE
CCCHHCCCHHHHCCC
29.7630278072
85PhosphorylationVEEQENETPPATSSE
HHHHCCCCCCCCCCC
46.2730278072
89PhosphorylationENETPPATSSEAEQP
CCCCCCCCCCCCCCC
38.2630576142
89UbiquitinationENETPPATSSEAEQP
CCCCCCCCCCCCCCC
38.2622817900
90PhosphorylationNETPPATSSEAEQPK
CCCCCCCCCCCCCCC
28.4325850435
90UbiquitinationNETPPATSSEAEQPK
CCCCCCCCCCCCCCC
28.4322817900
91PhosphorylationETPPATSSEAEQPKG
CCCCCCCCCCCCCCC
36.1530576142
92UbiquitinationTPPATSSEAEQPKGE
CCCCCCCCCCCCCCC
56.8622817900
93UbiquitinationPPATSSEAEQPKGEP
CCCCCCCCCCCCCCC
23.7521890473
93 (in isoform 2)Ubiquitination-23.7521890473
97SumoylationSSEAEQPKGEPENEE
CCCCCCCCCCCCCHH
75.5028112733
110PhosphorylationEEKEENKSSEETKKD
HHHHHCCCHHHHHHH
55.3426657352
111PhosphorylationEKEENKSSEETKKDE
HHHHCCCHHHHHHHH
40.8529255136
111UbiquitinationEKEENKSSEETKKDE
HHHHCCCHHHHHHHH
40.8524816145
114PhosphorylationENKSSEETKKDEKDQ
HCCCHHHHHHHHHHH
39.0723927012
121 (in isoform 5)Phosphorylation-68.4228634120
127UbiquitinationDQSKEKEKKVKKTIP
HHHHHHHHHHHHHHC
74.1422817900
128UbiquitinationQSKEKEKKVKKTIPS
HHHHHHHHHHHHHCH
61.4522817900
130UbiquitinationKEKEKKVKKTIPSWA
HHHHHHHHHHHCHHH
53.7522817900
131UbiquitinationEKEKKVKKTIPSWAT
HHHHHHHHHHCHHHH
55.4621890473
131 (in isoform 1)Ubiquitination-55.4621890473
132PhosphorylationKEKKVKKTIPSWATL
HHHHHHHHHCHHHHC
32.1919060867
132UbiquitinationKEKKVKKTIPSWATL
HHHHHHHHHCHHHHC
32.1932015554
135PhosphorylationKVKKTIPSWATLSAS
HHHHHHCHHHHCCHH
26.0322199227
138PhosphorylationKTIPSWATLSASQLA
HHHCHHHHCCHHHHH
18.2626657352
139 (in isoform 3)Ubiquitination-2.8821890473
140PhosphorylationIPSWATLSASQLARA
HCHHHHCCHHHHHHH
22.8625159151
142PhosphorylationSWATLSASQLARAQK
HHHHCCHHHHHHHHH
23.5017525332
146MethylationLSASQLARAQKQTPM
CCHHHHHHHHHHCCC
46.25115386917
149UbiquitinationSQLARAQKQTPMASS
HHHHHHHHHCCCCCC
55.9724816145
151PhosphorylationLARAQKQTPMASSPR
HHHHHHHCCCCCCCC
23.2823927012
155PhosphorylationQKQTPMASSPRPKMD
HHHCCCCCCCCHHHH
34.3230266825
156PhosphorylationKQTPMASSPRPKMDA
HHCCCCCCCCHHHHH
18.5229255136
160AcetylationMASSPRPKMDAILTE
CCCCCCHHHHHHHHH
51.1725953088
160UbiquitinationMASSPRPKMDAILTE
CCCCCCHHHHHHHHH
51.1729967540
166PhosphorylationPKMDAILTEAIKACF
HHHHHHHHHHHHHHH
19.7726074081
170UbiquitinationAILTEAIKACFQKSG
HHHHHHHHHHHHHCC
46.2632015554
175AcetylationAIKACFQKSGASVVA
HHHHHHHHCCCEEEE
30.5226051181
175UbiquitinationAIKACFQKSGASVVA
HHHHHHHHCCCEEEE
30.5229967540
176PhosphorylationIKACFQKSGASVVAI
HHHHHHHCCCEEEEE
28.8919691289
184UbiquitinationGASVVAIRKYIIHKY
CCEEEEEEHHHHHHC
18.9133845483
190AcetylationIRKYIIHKYPSLELE
EEHHHHHHCCCHHHH
48.7425825284
190MalonylationIRKYIIHKYPSLELE
EEHHHHHHCCCHHHH
48.7426320211
190UbiquitinationIRKYIIHKYPSLELE
EEHHHHHHCCCHHHH
48.7419608861
193PhosphorylationYIIHKYPSLELERRG
HHHHHCCCHHHHHHH
31.2425599653
204AcetylationERRGYLLKQALKREL
HHHHHHHHHHHHHHH
30.8127178108
204UbiquitinationERRGYLLKQALKREL
HHHHHHHHHHHHHHH
30.8129967540
220UbiquitinationRGVIKQVKGKGASGS
HCCCHHHCCCCCCCC
53.0324816145
222UbiquitinationVIKQVKGKGASGSFV
CCHHHCCCCCCCCEE
45.6533845483
225PhosphorylationQVKGKGASGSFVVVQ
HHCCCCCCCCEEEEE
43.5720860994
233UbiquitinationGSFVVVQKSRKTPQK
CCEEEEECCCCCCCC
40.3929967540
236UbiquitinationVVVQKSRKTPQKSRN
EEEECCCCCCCCCCC
72.1924816145
240AcetylationKSRKTPQKSRNRKNR
CCCCCCCCCCCCCCC
53.2212432513
245AcetylationPQKSRNRKNRSSAVD
CCCCCCCCCCCCCCC
61.3312432527
245UbiquitinationPQKSRNRKNRSSAVD
CCCCCCCCCCCCCCC
61.3333845483
248PhosphorylationSRNRKNRSSAVDPEP
CCCCCCCCCCCCCCC
31.8523401153
249PhosphorylationRNRKNRSSAVDPEPQ
CCCCCCCCCCCCCCC
29.1329255136
253UbiquitinationNRSSAVDPEPQVKLE
CCCCCCCCCCCCCHH
48.8721890473
253 (in isoform 2)Ubiquitination-48.8721890473
258SumoylationVDPEPQVKLEDVLPL
CCCCCCCCHHHHHHH
40.6928112733
258UbiquitinationVDPEPQVKLEDVLPL
CCCCCCCCHHHHHHH
40.6924816145
2742-HydroxyisobutyrylationFTRLCEPKEASYSLI
HHHHCCCHHHHHHHH
43.55-
274AcetylationFTRLCEPKEASYSLI
HHHHCCCHHHHHHHH
43.5526051181
274UbiquitinationFTRLCEPKEASYSLI
HHHHCCCHHHHHHHH
43.5524816145
277PhosphorylationLCEPKEASYSLIRKY
HCCCHHHHHHHHHHH
19.1528152594
278PhosphorylationCEPKEASYSLIRKYV
CCCHHHHHHHHHHHH
17.9728152594
279PhosphorylationEPKEASYSLIRKYVS
CCHHHHHHHHHHHHH
18.1528152594
282UbiquitinationEASYSLIRKYVSQYY
HHHHHHHHHHHHHHC
29.5523000965
2832-HydroxyisobutyrylationASYSLIRKYVSQYYP
HHHHHHHHHHHHHCH
42.90-
283AcetylationASYSLIRKYVSQYYP
HHHHHHHHHHHHHCH
42.9026051181
283UbiquitinationASYSLIRKYVSQYYP
HHHHHHHHHHHHHCH
42.9033845483
284PhosphorylationSYSLIRKYVSQYYPK
HHHHHHHHHHHHCHH
8.7628152594
286PhosphorylationSLIRKYVSQYYPKLR
HHHHHHHHHHCHHHC
14.9128152594
288PhosphorylationIRKYVSQYYPKLRVD
HHHHHHHHCHHHCCC
17.7728152594
289PhosphorylationRKYVSQYYPKLRVDI
HHHHHHHCHHHCCCC
6.0528152594
291AcetylationYVSQYYPKLRVDIRP
HHHHHCHHHCCCCHH
32.5726051181
291MalonylationYVSQYYPKLRVDIRP
HHHHHCHHHCCCCHH
32.5732601280
291UbiquitinationYVSQYYPKLRVDIRP
HHHHHCHHHCCCCHH
32.5722817900
291 (in isoform 1)Ubiquitination-32.5721890473
302AcetylationDIRPQLLKNALQRAV
CCHHHHHHHHHHHHH
49.0925953088
302UbiquitinationDIRPQLLKNALQRAV
CCHHHHHHHHHHHHH
49.0929967540
320UbiquitinationQLEQITGKGASGTFQ
CCEECCCCCCCCCEE
42.5323000965
323PhosphorylationQITGKGASGTFQLKK
ECCCCCCCCCEEECC
47.2128674419
327UbiquitinationKGASGTFQLKKSGEK
CCCCCCEEECCCCCC
52.8123000965
328UbiquitinationGASGTFQLKKSGEKP
CCCCCEEECCCCCCC
7.0623000965
329UbiquitinationASGTFQLKKSGEKPL
CCCCEEECCCCCCCC
33.8229967540
358PhosphorylationAAMNEPKTCSTTALK
HHHCCCCCCCHHHHH
23.5424043423
360PhosphorylationMNEPKTCSTTALKKY
HCCCCCCCHHHHHHH
33.7424043423
361PhosphorylationNEPKTCSTTALKKYV
CCCCCCCHHHHHHHH
20.4524043423
362PhosphorylationEPKTCSTTALKKYVL
CCCCCCHHHHHHHHH
17.4424043423
3652-HydroxyisobutyrylationTCSTTALKKYVLENH
CCCHHHHHHHHHHCC
39.33-
365AcetylationTCSTTALKKYVLENH
CCCHHHHHHHHHHCC
39.3325953088
365UbiquitinationTCSTTALKKYVLENH
CCCHHHHHHHHHHCC
39.3323000965
366UbiquitinationCSTTALKKYVLENHP
CCHHHHHHHHHHCCC
41.2523000965
367PhosphorylationSTTALKKYVLENHPG
CHHHHHHHHHHCCCC
14.5326356563
375PhosphorylationVLENHPGTNSNYQMH
HHHCCCCCCCHHHHH
39.6728152594
377PhosphorylationENHPGTNSNYQMHLL
HCCCCCCCHHHHHHH
36.4328152594
379PhosphorylationHPGTNSNYQMHLLKK
CCCCCCHHHHHHHHH
13.6627155012
385AcetylationNYQMHLLKKTLQKCE
HHHHHHHHHHHHHHH
50.5026051181
385UbiquitinationNYQMHLLKKTLQKCE
HHHHHHHHHHHHHHH
50.5029967540
393AcetylationKTLQKCEKNGWMEQI
HHHHHHHHCCHHHHH
70.9526051181
393UbiquitinationKTLQKCEKNGWMEQI
HHHHHHHHCCHHHHH
70.9529967540
403UbiquitinationWMEQISGKGFSGTFQ
HHHHHCCCCCCEEEE
50.41-
408PhosphorylationSGKGFSGTFQLCFPY
CCCCCCEEEEEECCC
13.6533259812
418PhosphorylationLCFPYYPSPGVLFPK
EECCCCCCCCCCCCC
20.40-
426UbiquitinationPGVLFPKKEPDDSRD
CCCCCCCCCCCCCCC
74.7824816145
430UbiquitinationFPKKEPDDSRDEDED
CCCCCCCCCCCCCCC
57.1833845483
431PhosphorylationPKKEPDDSRDEDEDE
CCCCCCCCCCCCCCC
49.3530175587
441PhosphorylationEDEDEDESSEEDSED
CCCCCCCCCCCCCCC
56.2028355574
442PhosphorylationDEDEDESSEEDSEDE
CCCCCCCCCCCCCCC
42.8528355574
444UbiquitinationDEDESSEEDSEDEEP
CCCCCCCCCCCCCCC
69.6424816145
446PhosphorylationDESSEEDSEDEEPPP
CCCCCCCCCCCCCCC
50.6728355574
461PhosphorylationKRRLQKKTPAKSPGK
CCCCCCCCCCCCCCC
35.2030576142
464UbiquitinationLQKKTPAKSPGKAAS
CCCCCCCCCCCCCHH
59.3924816145
465PhosphorylationQKKTPAKSPGKAASV
CCCCCCCCCCCCHHH
40.7825849741
468UbiquitinationTPAKSPGKAASVKQR
CCCCCCCCCHHHHHC
44.1333845483
480UbiquitinationKQRGSKPAPKVSAAQ
HHCCCCCCCCCCHHH
21.9324816145
482UbiquitinationRGSKPAPKVSAAQRG
CCCCCCCCCCHHHCC
51.4324816145
508UbiquitinationKAKTPAKKTRPSSTV
CCCCCCCCCCCCCEE
52.4524816145
509PhosphorylationAKTPAKKTRPSSTVI
CCCCCCCCCCCCEEE
47.2929396449
512PhosphorylationPAKKTRPSSTVIKKP
CCCCCCCCCEEEECC
35.0428985074
513PhosphorylationAKKTRPSSTVIKKPS
CCCCCCCCEEEECCC
29.4029970186
514PhosphorylationKKTRPSSTVIKKPSG
CCCCCCCEEEECCCC
30.5029396449
518UbiquitinationPSSTVIKKPSGGSSK
CCCEEEECCCCCCCC
33.0424816145
520PhosphorylationSTVIKKPSGGSSKKP
CEEEECCCCCCCCCC
65.7424732914
523PhosphorylationIKKPSGGSSKKPATS
EECCCCCCCCCCCCC
42.3724732914
524PhosphorylationKKPSGGSSKKPATSA
ECCCCCCCCCCCCCC
48.2324732914
529PhosphorylationGSSKKPATSARKEVK
CCCCCCCCCCCCCCC
31.2922817900
530PhosphorylationSSKKPATSARKEVKL
CCCCCCCCCCCCCCC
28.3422817900
533AcetylationKPATSARKEVKLPGK
CCCCCCCCCCCCCCC
67.5826051181
536AcetylationTSARKEVKLPGKGKS
CCCCCCCCCCCCCCC
50.4825953088
544PhosphorylationLPGKGKSTMKKSFRV
CCCCCCCCCCHHHCC
36.17-
546UbiquitinationGKGKSTMKKSFRVKK
CCCCCCCCHHHCCCC
45.4124816145
548PhosphorylationGKSTMKKSFRVKK--
CCCCCCHHHCCCC--
16.8720068230

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of HP1B3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of HP1B3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of HP1B3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049
LMNB1_HUMANLMNB1physical
22939629
PCDA2_HUMANPCDHA2physical
22939629
NOP16_HUMANNOP16physical
22939629
LAP2A_HUMANTMPOphysical
22939629
LAP2B_HUMANTMPOphysical
22939629
LAMP2_HUMANLAMP2physical
22939629
RS24_HUMANRPS24physical
22939629
SON_HUMANSONphysical
22939629
ZN326_HUMANZNF326physical
22939629
K2C3_HUMANKRT3physical
22939629
RL1D1_HUMANRSL1D1physical
22939629
RRP7A_HUMANRRP7Aphysical
22939629
UT14A_HUMANUTP14Aphysical
22939629
SURF4_HUMANSURF4physical
22939629
RL5_HUMANRPL5physical
22939629
NFIA_HUMANNFIAphysical
22939629
NXF1_HUMANNXF1physical
22939629
SPB1_HUMANFTSJ3physical
22939629
TPBG_HUMANTPBGphysical
22939629
TRA2A_HUMANTRA2Aphysical
22939629
MIC60_HUMANIMMTphysical
22939629
NOP2_HUMANNOP2physical
22939629
RS14_HUMANRPS14physical
22939629
SRSF7_HUMANSRSF7physical
22939629
VTNC_HUMANVTNphysical
22939629
ZCH18_HUMANZC3H18physical
22939629
RBM14_HUMANRBM14physical
22939629
LN28A_HUMANLIN28Aphysical
24778252
TRBP2_HUMANTARBP2physical
24778252
IPO7_HUMANIPO7physical
28514442
DDI2_HUMANDDI2physical
28514442
NUSAP_HUMANNUSAP1physical
28514442
RL30_HUMANRPL30physical
28514442
IPO8_HUMANIPO8physical
28514442
IMB1_HUMANKPNB1physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of HP1B3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-190, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-248 AND SER-249, ANDMASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; SER-442 ANDSER-446, AND MASS SPECTROMETRY.
"Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction.";
Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
Mol. Cell. Proteomics 6:1952-1967(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-132 AND SER-142, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6 AND SER-156, AND MASSSPECTROMETRY.

TOP